You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Colorectal cancer

Dostarlimab for untreated locally advanced rectal cancer with high microsatellite instability or mismatch repair deficiency [ID6747]

  • Awaiting development
  • Reference number: GID-TA11972
  • Expected publication date: TBC
  • Project information
  • Project documents

37011-Dostarlimab-for-Rectal-Cancer-V1.0-DEC2025-NON-CONF.pdf

Back to top